Abstract P1-18-18: PIK3CA mutation testing prevalence among post-menopausal (PM) women with hormone receptor positive and human epidermal growth factor receptor 2 negative (HR+/HER2-) metastatic breast cancer (mBC) using real world data

Authors: Nicole Princic, Qayyim Said, David Smith, William Johnson, Ayal Aizer

Published: 2020-03-26

DOI: 10.1158/1538-7445.sabcs19-p1-18-18

Source: Full article